[{"id":"42863ddc-f4db-4ccc-bee0-c2c0b6477bd7","acronym":"","url":"https://clinicaltrials.gov/study/NCT03300817","created_at":"2024-01-03T14:17:29.800Z","updated_at":"2024-07-02T16:34:26.572Z","phase":"Phase 1","brief_title":"MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer","source_id_and_acronym":"NCT03300817","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" IL6 • MUC1 • CRP","pipe":"","alterations":" ","tags":["IL6 • MUC1 • CRP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Undisclosed MUC1 peptide-poly-ICLC adjuvant vaccine"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 12/27/2017","start_date":" 12/27/2017","primary_txt":" Primary completion: 09/23/2021","primary_completion_date":" 09/23/2021","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2024-06-13"},{"id":"0461c7a7-21e2-4e81-904b-eaaa59fe9275","acronym":"","url":"https://clinicaltrials.gov/study/NCT00773097","created_at":"2021-01-18T02:55:17.301Z","updated_at":"2024-07-02T16:37:04.205Z","phase":"Phase 2","brief_title":"Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma","source_id_and_acronym":"NCT00773097","lead_sponsor":"Robert Schoen","biomarkers":" MUC1","pipe":"","alterations":" ","tags":["MUC1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Hiltonol (poly-ICLC) • Undisclosed MUC1 peptide-poly-ICLC adjuvant vaccine"],"overall_status":"Completed","enrollment":" Enrollment 46","initiation":"Initiation: 10/01/2008","start_date":" 10/01/2008","primary_txt":" Primary completion: 10/01/2011","primary_completion_date":" 10/01/2011","study_txt":" Completion: 10/01/2012","study_completion_date":" 10/01/2012","last_update_posted":"2019-01-07"},{"id":"d5a5d382-3dc7-43ba-b500-f8f5514fbf4d","acronym":"","url":"https://clinicaltrials.gov/study/NCT00986609","created_at":"2021-01-18T03:51:10.668Z","updated_at":"2024-07-02T16:37:08.764Z","phase":"Phase 1","brief_title":"MUC1 Vaccine for Triple-negative Breast Cancer","source_id_and_acronym":"NCT00986609","lead_sponsor":"Joseph Baar, MD, PhD","biomarkers":" HER-2 • PGR","pipe":"","alterations":" ","tags":["HER-2 • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Hiltonol (poly-ICLC) • Undisclosed MUC1 peptide-poly-ICLC adjuvant vaccine"],"overall_status":"Completed","enrollment":" Enrollment 29","initiation":"Initiation: 08/19/2009","start_date":" 08/19/2009","primary_txt":" Primary completion: 08/29/2013","primary_completion_date":" 08/29/2013","study_txt":" Completion: 01/21/2016","study_completion_date":" 01/21/2016","last_update_posted":"2018-07-23"}]